NCT07195175View on ClinicalTrials.gov

Study of MAR002 in Healthy Men

PHASE1RecruitingINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Acromegaly

Interventions

DRUG

MAR002

subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Trial Locations (1)

85283

RECRUITING

Marea Site, Tempe

Sponsors

Lead Sponsor

Marea Therapeutics

All Listed Sponsors

lead

Marea Therapeutics

INDUSTRY